Nelson Testbook Pediatric 19th edition, State epilepticus, Elsevier Chin RF, Neville BG, Peckham C, Wade A, Bedford H, Scott RC. Treatment of community-onset, childhood convulsive status epilepticus: a prospec-tive, population-based study. Lancet Neurol 2008;7(8):696-703. Shinnar S, Hesdorffer DC. Pediatric status epilepticus: should the diagnos-tic evaluation change? Neurology 2010;74(8):624-5. Chin RF, Neville BG, Peckham C, Bedford H, Wade A, Scott RC; NLSTEPSS Collaborative Group. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 2006;368(9531):222-9. Yeghiazaryan NS, Zara F, Capovilla G, Brigati G, Falsaperla R, Striano P. Pyridoxine-dependent epilepsy: an under-recognised cause of intractable seizures. J Paediatr Child Health 2012;48(3):E113-5. Trinka E, Hòfler J, Zerbs A, Brigo F. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review. CNS Drugs 2014;28(7):623-39. McTague A, Kneen R, Kumar R, Spinty S, Appleton R. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital. Seizure 2012;21(7):529-34. van Gestel JP, Blussé van Oud-Alblas HJ, Malingré M, Ververs FF, Braun KP, van Nieuwenhuizen O. Propofol and thiopental for refractory status epilepticus in children. Neurology 2005;65(4):591-2.